MEDVAL is pleased to announce its new Post-Settlement Administration Services offered through MEDVAL Rx. These services are available to individuals who have funds in a Medicare-Set-Aside (MSA) account to pay for future prescription expenses. MEDVAL Rx historically limited these services to MSAs that were professionally administered, but all self-administered MSA accounts, regardless of which vendor […] Continue
On Monday, the comment period for the Centers for Medicare & Medicaid’s (CMS) Section 111 Civil Money Penalties (CMPs) proposed rule closed. Entities that are responsible for complying with Section 111 reporting, and subsequently which may be subject to CMPs are referred to as Responsible Reporting Entities (RREs). These entities must provide specific data on […] Continue
The impact of COVID-19 has undoubtedly been profound, but some of its effects are less obvious than others. One of the impacts associated with the COVID-19 pandemic that may not have hit home yet for many is the likely effect on the pipeline of new drug approvals through the FDA. The pandemic will likely produce […] Continue
Mobic (meloxicam) is a nonsteroidal anti-inflammatory drug (NSAID) commonly seen in workers’ compensation claims. It is most frequently prescribed to treat osteoarthritis (OA) starting at doses of 7.5 mg and may be increased to 15 mg daily to reduce pain, joint swelling, and stiffness in joints. Recently, the average wholesale price of this medication dropped […] Continue
In 2019, Medicare started covering some virtual care services. The services covered included brief communications and Virtual Check-Ins (short patient-initiated communications with a healthcare practitioner) along with E-visits (which are non-face-to-face patient-initiated communications through an online patient portal). However, telehealth services have generally not been covered. Historically, for telehealth services to be covered, certain circumstances […] Continue